1. Home
  2. CYTK vs CNH Comparison

CYTK vs CNH Comparison

Compare CYTK & CNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$75.87

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo CNH Industrial N.V.

CNH

CNH Industrial N.V.

N/A

Current Price

$10.29

Market Cap

12.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
CNH
Founded
1997
1842
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.7B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
CYTK
CNH
Price
$75.87
$10.29
Analyst Decision
Strong Buy
Buy
Analyst Count
19
11
Target Price
$89.26
$13.00
AVG Volume (30 Days)
1.8M
15.3M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
0.99%
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
$13,368,000.00
$18,095,000,000.00
Revenue This Year
$7.37
N/A
Revenue Next Year
$310.19
$8.21
P/E Ratio
N/A
$87.00
Revenue Growth
N/A
N/A
52 Week Low
$35.22
$9.00
52 Week High
$88.31
$13.31

Technical Indicators

Market Signals
Indicator
CYTK
CNH
Relative Strength Index (RSI) 41.75 45.91
Support Level $73.95 $10.06
Resistance Level $80.65 $11.20
Average True Range (ATR) 2.94 0.46
MACD -0.58 -0.05
Stochastic Oscillator 26.45 15.71

Price Performance

Historical Comparison
CYTK
CNH

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agricultural sales are 40% in North America, 32% in Europe, the Middle East, and Africa, 18% in South America, and 10% in Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers and wholesale financing to dealers to maintain inventory, thereby supporting sales.

Share on Social Networks: